Phathom Pharmaceuticals, Inc.
PHATAs of the close on Sep 25, 2026
Price
$7.30
Market cap
$591M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$1.25
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Phathom Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 27, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 1,387 | $15.4K | SEC filing |
| CANADA LIFE ASSURANCE Co | 2026-03-31 | 6,818 | Not shown | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 626,196 | $6.96M | SEC filing |
| IFP Advisors, Inc | 2026-03-31 | 1 | $11 | SEC filing |
| Simplify Asset Management Inc. | 2026-03-31 | 262,386 | $2.92M | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 1,198 | $13.3K | SEC filing |
| Schonfeld Strategic Advisors LLC | 2026-03-31 | 15,614 | $173K | SEC filing |
| Campbell & CO Investment Adviser LLC | 2026-03-31 | 62,023 | $689K | SEC filing |
| Ameritas Investment Partners, Inc. | 2026-03-31 | 3,527 | $39.2K | SEC filing |
| Rachor Investment Advisory Services, LLC | 2026-03-31 | 25 | $278 | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 11,348 | $126K | SEC filing |
| GROUP ONE TRADING LLC | 2026-03-31 | 16,939 | $188K | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 11,332 | $126K | SEC filing |
| MAI Capital Management | 2026-03-31 | 23 | $256 | SEC filing |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 2026-03-31 | 55,788 | $620K | SEC filing |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 21,732 | $241K | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 1,941 | $21.6K | SEC filing |
| Kera Capital Partners, Inc. | 2026-03-31 | 26,826 | $298K | SEC filing |
| Persistent Asset Partners Ltd | 2026-03-31 | 26,766 | $297K | SEC filing |
| Jump Financial, LLC | 2026-03-31 | 26,445 | $294K | SEC filing |
- Each value is checked against Phathom Pharmaceuticals, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Phathom Pharmaceuticals, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Phathom Pharmaceuticals, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-05-09 · Topper James N: Larger than all 23 other insider purchases of Common Stock on file. SEC filing
- 2025-01-21 · Curran Terrie: Larger than 64 of the 69 other insider sales of Common Stock on file. SEC filing
- 2024-07-15 · Curran Terrie: Larger than 67 of the 69 other insider sales of Common Stock on file. SEC filing
- 2024-03-22 · Curran Terrie: Larger than 63 of the 69 other insider sales of Common Stock on file. SEC filing
- 2024-01-24 · TAKEDA PHARMACEUTICAL CO LTD: Larger than all 69 other insider sales of Common Stock on file. SEC filing
- 2022-05-16 · Nabulsi Azmi: Larger than 21 of the 23 other insider purchases of Common Stock on file. SEC filing
- 2022-05-13 · Curran Terrie: Larger than 22 of the 23 other insider purchases of Common Stock on file. SEC filing
- 2021-11-04 · TAKEDA PHARMACEUTICAL CO LTD: Larger than 68 of the 69 other insider sales of Common Stock on file. SEC filing
- 2021-06-28 · Socks David A: Larger than 66 of the 69 other insider sales of Common Stock on file. SEC filing
- 2021-06-25 · TAKEDA PHARMACEUTICAL CO LTD: Larger than 65 of the 69 other insider sales of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-05-07–2025-05-14: 6 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2025-05-06–2025-05-13: 6 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2024-12-13–2024-12-13: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2023-04-06–2023-04-11: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
- 2022-05-12–2022-05-16: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-03 | Breedlove Robert Charles · Principal Accounting Officer | Common Stock | S — Open market or private sale | −524 | 13.51 | SEC filing |
| 2025-09-05 | Breedlove Robert Charles · Principal Accounting Officer | Common Stock | S — Open market or private sale | −461 | 12.09 | SEC filing |
| 2025-07-16 | Breedlove Robert Charles · Principal Accounting Officer | Common Stock | S — Open market or private sale | −1,692 | 8.36 | SEC filing |
| 2025-05-21 | Topper James N · Director | Common Stock | P — Open market or private purchase | +3,780 | 3.86 | SEC filing |
| 2025-05-14 | Topper James N · Director | Common Stock | P — Open market or private purchase | +6,300 | 3.32 | SEC filing |
| 2025-05-13 | Topper James N · Director | Common Stock | P — Open market or private purchase | +1,120 | 3.16 | SEC filing |
| 2025-05-12 | Topper James N · Director | Common Stock | P — Open market or private purchase | +12,601 | 3.04 | SEC filing |
| 2025-05-09 | Topper James N · Director | Common Stock | P — Open market or private purchase | +2,226 | 3.62 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-22 | Parikh Asit · Director | Common Stock | G — Bona fide gift | +28,000 | SEC filing |
| 2026-05-22 | Parikh Asit · Director | Common Stock | G — Bona fide gift | −28,000 | SEC filing |
| 2026-05-20 | Parikh Asit · Director | Common Stock | M — Exercise or conversion of derivative security | +17,500 | SEC filing |
| 2026-05-19 | Stenhouse Mark · Director | Common Stock | A — Grant, award, or other acquisition | +24,122 | SEC filing |
| 2026-05-19 | COLA MICHAEL F · Director | Common Stock | A — Grant, award, or other acquisition | +24,122 | SEC filing |
| 2026-05-19 | Schroeder Theodore R · Director | Common Stock | A — Grant, award, or other acquisition | +24,122 | SEC filing |
| 2026-05-19 | Topper James N · Director, 10% owner | Common Stock | A — Grant, award, or other acquisition | +24,122 | SEC filing |
| 2026-05-19 | KARBE FRANK · Director | Common Stock | A — Grant, award, or other acquisition | +24,122 | SEC filing |
Showing 8 of 36 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-20 | Parikh Asit · Director | Common Stock (Right to Buy) | D — Disposition to the issuer | −17,500 | SEC filing |
| 2023-07-14 | Curran Terrie · President and Chief Executive | Stock Option | D — Disposition to the issuer | −225,000 | SEC filing |
| 2023-07-14 | Nabulsi Azmi · Chief Operating Officer | Stock Option | D — Disposition to the issuer | −150,000 | SEC filing |
| 2023-07-14 | Curran Terrie · President and Chief Executive | Stock Option | D — Disposition to the issuer | −175,000 | SEC filing |
| 2023-07-14 | Nabulsi Azmi · Chief Operating Officer | Stock Option | D — Disposition to the issuer | −70,000 | SEC filing |
| 2023-06-02 | Parikh Asit · Director | Stock Option (Right to Buy) | D — Disposition to the issuer | −15,000 | SEC filing |
Showing 6 of 6 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.